Targeting DNA damage in SCLC. [electronic resource]
Producer: 20180131Description: 12-22 p. digitalISSN:- 1872-8332
- Aurora Kinases -- therapeutic use
- Azepines -- therapeutic use
- Benzimidazoles -- therapeutic use
- Carbolines -- therapeutic use
- Cell Cycle Checkpoints -- drug effects
- Cell Proliferation -- drug effects
- Cytotoxins -- therapeutic use
- DNA Damage -- drug effects
- DNA Repair
- Etoposide -- therapeutic use
- Genomic Instability -- drug effects
- Heterocyclic Compounds, 4 or More Rings -- therapeutic use
- Humans
- Lung Neoplasms -- drug therapy
- Molecular Targeted Therapy -- methods
- Phthalazines -- therapeutic use
- Piperazines -- therapeutic use
- Poly(ADP-ribose) Polymerase Inhibitors -- therapeutic use
- Protein Kinase Inhibitors -- therapeutic use
- Pyrimidines -- therapeutic use
- Rad51 Recombinase -- antagonists & inhibitors
- Small Cell Lung Carcinoma -- drug therapy
No physical items for this record
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.